Cmic Of Japan Expands Abroad To Chase Contract Profits
This article was originally published in PharmAsia News
Executive SummaryJapan's Cmic, which produces drugs on contract, expects to make its first profit in three years by the end of September
You may also be interested in...
Genomic profiling firm Foundation Medicine hires new chief commercial officer; Bardy Diagnostics, developer of cardiac arrhythmia devices, picks a chief operating officer; Lantheus Medical Imaging, producer of diagnostic imaging agents and products; brings aboard a new chief medical officer; and more.